Le cluster Radioimmunotherapy (adverse effects) - Thyroid Neoplasms (radiotherapy)
| 000023 (2012) | Pierre-Yves Salaun (France) ; Loïc Campion ; Claire Bournaud ; Alain Faivre-Chauvet ; Jean-Philippe Vuillez ; David Taieb ; Catherine Ansquer ; Caroline Rousseau ; Françoise Borson-Chazot ; Stéphane Bardet ; Aurore Oudoux ; Bertrand Cariou ; Eric Mirallié ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Françoise Kraeber-Bodéré | Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement. |
| 000094 (2006) | Françoise Kraeber-Bodéré (France) ; Caroline Rousseau ; Caroline Bodet-Milin ; Ludovic Ferrer ; Alain Faivre-Chauvet ; Loïc Campion ; Jean-Philippe Vuillez ; Anne Devillers ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet | Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. |
| 000160 (1999) | F Kraeber-Bodéré (France) ; A Faivre-Chauvet ; C Saï-Maurel ; L Campion ; M Fiche ; E Gautherot ; J Le Boterff ; J Barbet ; J F Chatal ; P Thédrez | Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. |
| 000095 (2006) | Jean-François Chatal (France) ; Loïc Campion ; Françoise Kraeber-Bodéré ; Stephane Bardet ; Jean-Philippe Vuillez ; Bernard Charbonnel ; Vincent Rohmer ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jacques Barbet ; | Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group. |
| 000166 (1999) | E Gautherot (France) ; F Kraeber-Bodéré ; L Daniel ; M Fiche ; E Rouvier ; C Saï-Maurel ; P Thedrez ; J F Chatal ; J Barbet | Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. |
| 000022 (2012) | Françoise Kraeber-Bodéré (France) ; Pierre-Yves Salaun ; Catherine Ansquer ; Delphine Drui ; Eric Mirallié ; Alain Faivre-Chauvet ; Jacques Barbet ; David M Goldenberg ; Jean-François Chatal | Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC). |
| 000116 (2005) | Eric Mirallié (France) ; Catherine Saï-Maurel ; Alain Faivre-Chauvet ; Nicolas Regenet ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Philippe Thedrez | Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody. |
| 000125 (2004) | Francesco Giammarile (France) ; Claire Houzard ; Claire Bournaud ; Zakia Hafdi ; Genevieve Sassolas ; Francoise Borson-Chazot | Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans. |
| 000129 (2003) | Françoise Kraeber-Bodéré (France) ; Alain Faivre-Chauvet ; Ludovic Ferrer ; Jean-Philippe Vuillez ; Pierre-Yves Brard ; Caroline Rousseau ; Isabelle Resche ; Anne Devillers ; Sophie Laffont ; Manuel Bardiès ; Ken Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet | Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial. |
| 000139 (2002) | Françoise Kraeber-Bodéré (France) ; Catherine Saï-Maurel ; Loïc Campion ; Alain Faivre-Chauvet ; Eric Mirallié ; Michel Chérel ; Stéphane Supiot ; Jacques Barbet ; Jean-François Chatal ; Philippe Thédrez | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. |
| 000186 (1997) | C Pérault (France) ; C Schvartz ; H Wampach ; J C Liehn ; M J Delisle | Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. |
| 000199 (1996) | E Baudin (France) ; M Schlumberger ; J Lumbroso ; J P Travagli ; B Caillou ; C Parmentier | Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. |
| 000208 (1996) | A Devys (France) ; P Thedrez ; E Gautherot ; A Faivre-Chauvet ; C Saï-Maurel ; E Rouvier ; J L Auget ; J Barbet ; J F Chatal | Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques. |
| 000213 (1995) | F Tenenbaum (France) ; J Lumbroso ; M Schlumberger ; B Caillou ; P Fragu ; C Parmentier | Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma. |
| 000254 (1992) | M Bardiès (France) ; P Thedrez ; J F Gestin ; B M Marcille ; D Guerreau ; A Faivre-Chauvet ; M Mahé ; C Sai-Maurel ; J F Chatal | Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluation. |
| 000261 (1992) | J M Le Doussal (France) ; J Barbet ; M Delaage | Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results. |
| This area was generated with Dilib version V0.5.76. |  |